One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Resuscitation Using ECPR During In-Hospital Cardiac Arrest (RESCUE-IHCA) Mortality Prediction Score and External Validation
Joseph E.TonnaMD, MSabCraig H.SelzmanMDaSaketGirotraMD, SMcAngela P.PressonPhDdRavi R.ThiagarajanMBBS, MPHeLance B.BeckerMDfChongZhangMSdPeterRycusMPHgHeather T.KeenanMDCM, PhDhAmerican Heart Association Get With the Guidelines–Resuscitation Investigators
The Tool Is Only as Good as the Person Who Wields It
DemetrisYannopoulosMDabJason A.BartosMD, PhDab
Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
YanYanMDabc∗WeiGongMDabc∗ChangshengMaMDcXiaoWangMDabcSidney C.SmithJr.MDdGregg C.FonarowMDeLouiseMorganMSNfJingLiuMD, PhDgEricVicautMD, PhDhDongZhaoMD, PhDgGillesMontalescotMD, PhDiShaopingNieMD, PhDabcCCC-ACS Investigators
Anticoagulation After Primary PCI: The Land of Promises and Uncertainty
FeliceGragnanoMD, PhDabPaoloCalabròMD, PhDab
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes
ClaudioLaudaniMDaAntonioGrecoMDaGiovanniOcchipintiMDaSalvatoreIngalaMDaDarioCalderoneMDaLorenzoScaliaMDaFedericaAgnelloMDaMarcoLegnazziMDaMaria SaraMauroMDaCarlaRochiraMDaSergioBuccheriMDbRoxanaMehranMDcStefanJamesMDbDominick J.AngiolilloMD, PhDdDavideCapodannoMD, PhDa
DES and DAPT in Evolution: Will Clinical Guidelines Follow?
Dean J.KereiakesMDaRobert W.YehMD, MScb
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy
MauroChiaritoMDabc∗UsmanBaberMD, MSad∗DavideCaoMDaSamin K.SharmaMDaGeorgeDangasMD, PhDaDominick J.AngiolilloMD, PhDeCarloBriguoriMD, PhDfDavid J.CohenMDghDariuszDudekMD, PhDiVladimÃrDžavÃkMDjJavierEscanedMD, PhDkRobertGilMDlChristian W.HammMDmTimothyHenryMDnKurtHuberMDoAdnanKastratiMDpUpendraKaulMDqRanKornowskiMDr…RoxanaMehranMDa
Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction: The Twilight of Prolonged DAPT Duration?
Eli I.LevMDEyalBen-AssaMD
Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries
MichaelMegalyMD, MSa∗KevinBudaDOb∗KhaldoonAlaswadMDaEmmanouil S.BrilakisMD, PhDcAllisonDupontMDdSrihariNaiduMDeMagnusOhmanMDfL. ChristianNappMDgWilliamO’NeillMDaMir B.BasirDOa
Trials, Tribunals, and Opportunities in Cardiogenic Shock Research
SaraschandraVallabhajosyulaMD, MSc
Balloon-Expandable Cheatham-Platinum Stents Versus Self-Expandable Nitinol Stents in Coarctation of Aorta: AÂ Randomized Controlled Trial
ParhamSadeghipourMDaBahramMohebbiMDaAtaFirouziMDaZahraKhajaliMDbSedighehSaediMDbOmidShafeMDaHamid RezaPouraliakbarMDbMohammad JavadAlemzadeh-AnsariMDaShabnamShahdiMDbNiloufarSamieiMDcAnitaSadeghpourMDcMohammadrezaBabaeiMDdBehshidGhadrdoostPhDaAryaAfroogheMDdMehradRokniMDaMohammad AminDabbagh OhadiMDeZahraHosseiniMDaSeifollahAbdiMDa…JamalMoosaviMDa
Efficacy of Self-Expandable Stents in Native Aortic Coarctation: A Single Flower Does Not Mean Spring (Persian Proverb)
SébastienHascoëtMDabClémentKarsentyMDcdAlainFraisseMDb
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM Study
Monique E.A.M.van KleefMD, PhDaChandan M.DevireddyMD, MBAbJanvan der HeydenMD, PhDcMark C.BatesMD, DScdGeorge L.BakrisMDeGregg W.StoneMDfBryanWilliamsMDgWilkoSpieringMD, PhDaCALM-FIM Investigators
Carotid Implants to Treat Resistant Arterial Hypertension: A Paradigm for the Collaboration Between Clinicians and Interventionalists
GiuseppeAndòMD, PhDaThaboMahendiranMDbVictoriaAndòMDc
Carotid Implants to Treat Resistant Arterial Hypertension: A Paradigm for the Collaboration Between Clinicians and Interventionalists
ArianaGonzálvez-GarcÃaMDaIgnacioSánchez-PérezMDaFernando LozanoRuÃz-PovedaMD, PhDaSantiagoJiménez-ValeroMDbFrancisco JavierRuÃz-LorenzoMD, PhDcCarlosPastor-SánchezMDdAlfonsoFreites-EstevesMDa
An Unexpected Cause of Very Late Stent Thrombosis
SandraMayordomoMDaEduardo J.LezcanoMD, PhDaFélix J.RoblesMDaRicardoSalgadoMD, PhDb
A Novel Closed-Loop Balloon-Stent Technique for Vessel Closure
Mustafa TarıkAğaçMDMehmet BülentVatanMDErsanTatlıMD
Lipomatous Atrial Septal Hypertrophy and Atrial Septal Defect With Rim Deficiency
HiroyaTakafujiMDKotaroObunaiMDNahokoKatoMD, PhDMasakiHondaMDHiroyukiWatanabeMD, PhD
Cryptogenic Stroke–Associated Atrial Septal Defect With Right Ventricular Myocardial Infarction
HiroyaTakafujiMDKotaroObunaiMDKazuhiroAsanoMDHidewoAmanoMDNahokoKatoMD, PhDHiroyukiWatanabeMD, PhD
Half-Dose DOAC After Watchman Implantation
EduardoFlores-UmanzorMD, PhDPedroCepas-GuillenMD, PhDAnderRegueiroMD, PhDLauraSanchisMD, PhDCristinaIbañezMDMartaSitgesMD, PhDJosepRodes-CabauMD, PhDXavierFreixaMD, PhD
Reply: Half-Dose DOAC After Watchman Implantation
Domenico GiovanniDella RoccaMD, PhDAndreaNataleMD
Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice and the ISCHEMIA Trial Population
BobanThomasMDSofiaThomasImadHassanMD
Reply: Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice and the ISCHEMIA Trial Population
JayGiriMD, MPHSauravChatterjeeMD
Pathophysiological Entity or Imaging-Based Risk Score?: A Controversial Interpretation of the Ratio
RobinLe RuzMD
Reply: Pathophysiological Entity or Imaging-Based Risk Score?: A Controversial Interpretation of the Ratio
Michael I.BrenerMDPaulGrayburnMDMichael J.MackMDGregg W.StoneMDRebecca T.HahnMD
Safety and Efficacy of Single-Access Impella for High-Risk Percutaneous Intervention (SHiP)
AbdulHakeemMDDelphineTangDOKushPatelMDAnkurSethiMDAshishAwasthiMDRamzanZakirMDTudorVagaonescuMD
Retrograde Access for the Recanalization of Lower-Limb Occlusive Lesions: A German Experience Report in 1,516 Consecutive Patients
GrigoriosKorosoglouMDAndrejSchmidtMDKonstantinosStavroulakisMDDanielaPollertMDSorinGiuscaMDMichaelLichtenbergMDDierkScheinertMDGiovanniTorselloMDMartinAndrassyMDErwinBlessingMD
